Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Stem Cells. Apr 26, 2023; 15(4): 248-267
Published online Apr 26, 2023. doi: 10.4252/wjsc.v15.i4.248
Published online Apr 26, 2023. doi: 10.4252/wjsc.v15.i4.248
Bone marrow mesenchymal stem cell-derived exosomal microRNAs target PI3K/Akt signaling pathway to promote the activation of fibroblasts
Fang-Qi Li, Wen-Bo Chen, Zhi-Wen Luo, Yi-Sheng Chen, Ya-Ying Sun, Shi-Yi Chen, Department of Sports Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China
Xiao-Ping Su, Guangxi Key Laboratory of Oral and Maxillofacial Rehabilitation and Reconstruction, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China
Jun-Ming Sun, Laboratory Animal Center, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China
Author contributions: Li FQ, Chen WB, and Chen YS designed and performed most of the experiments, analyzed and interpreted the data, and wrote the manuscript; Luo ZW and Sun YY assisted during the acquisition, analysis, and interpretation of data and revised the manuscript; and all authors have reviewed and approved the final manuscript. Li FQ, Chen WB, and Luo ZW contributed equally to this study. Su XP (xiaopingsu2013@aliyun.com), Sun JM (sjm990205@163.com), and Chen SY (cshiyi@163.com) correspond to this study.
Supported by Sanming Project of Medicine in Shenzhen , No. SZSM201612078 ; Health Shanghai Initiative Special Fund (Medical-Sports Integration , Creating a New Model of Exercise for Health), No. JKSHZX-2022-02.
Institutional review board statement: This study involves no human or animal subjects.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Shi-Yi Chen, Doctor, MD, PhD, Academic Editor, Academic Fellow, Chairman, Department of Sports Medicine, Huashan Hospital, Fudan University, No. 12 Middle Wulumuqi Road, Jing’an District, Shanghai 200040, China. cshiyi@163.com
Received: November 23, 2022
Peer-review started: November 23, 2022
First decision: January 6, 2023
Revised: January 19, 2023
Accepted: March 23, 2023
Article in press: March 23, 2023
Published online: April 26, 2023
Processing time: 153 Days and 15.3 Hours
Peer-review started: November 23, 2022
First decision: January 6, 2023
Revised: January 19, 2023
Accepted: March 23, 2023
Article in press: March 23, 2023
Published online: April 26, 2023
Processing time: 153 Days and 15.3 Hours
Core Tip
Core Tip: Exosomes derived from bone marrow mesenchymal stem cells (BMSCs) can activate fibroblasts and promote tendon-bone healing via the contained microRNAs (miRNAs). Supported by bioinformatics tools, this study identified two BMSC-derived exosomal miRNAs, has-miR-144-3p and has-miR-23b-3p, were overlapped in three GSE datasets. Bioinformatic analysis revealed that both miRNAs regulated the PI3K/Akt signaling pathway by targeting phosphatase and tensin homolog (PTEN). Experiments in vitro confirmed that interfering with PTEN can affect the phosphorylation of Akt and thus the activation of fibroblasts. These results suggested a potential mechanism by which BMSC-derived exosomes promote tendon-bone healing.